Bayview Legacy, Llc Sells 47,244 Shares of Arteris (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) major shareholder Bayview Legacy, Llc sold 47,244 shares of the company’s stock in a transaction dated Monday, February 9th. The shares were sold at an average price of $15.21, for a total transaction of $718,581.24. Following the completion of the transaction, the insider owned 9,351,827 shares in the company, valued at $142,241,288.67. This trade represents a 0.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Large shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Bayview Legacy, Llc also recently made the following trade(s):

• On Tuesday, February 10th, Bayview Legacy, Llc sold 2,756 shares of Arteris stock. The stock was sold at an average price of $15.03, for a total transaction of $41,422.68.
• On Thursday, January 15th, Bayview Legacy, Llc sold 17,884 shares of Arteris stock. The shares were sold at an average price of $17.84, for a total transaction of $319,050.56.
• On Tuesday, January 13th, Bayview Legacy, Llc sold 2,116 shares of Arteris stock. The stock was sold at an average price of $17.79, for a total transaction of $37,643.64.
• On Thursday, January 8th, Bayview Legacy, Llc sold 50,000 shares of Arteris stock. The stock was sold at an average price of $16.58, for a total transaction of $829,000.00.
• On Monday, December 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The shares were sold at an average price of $17.71, for a total transaction of $1,239,700.00.
• On Friday, December 5th, Bayview Legacy, Llc sold 60,000 shares of Arteris stock. The shares were sold at an average price of $17.08, for a total value of $1,024,800.00.
• On Thursday, December 4th, Bayview Legacy, Llc sold 40,000 shares of Arteris stock. The stock was sold at an average price of $16.46, for a total value of $658,400.00.

Arteris Price Performance

Arteris stock opened at $14.92 on Friday. The firm has a market cap of $651.71 million, a PE ratio of -17.98 and a beta of 1.47. The stock’s fifty day moving average price is $16.28 and its two-hundred day moving average price is $13.24. Arteris, Inc. has a one year low of $5.46 and a one year high of $19.85.

Arteris (NASDAQ:AIP) last released its earnings results on Thursday, February 12th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $20.14 million for the quarter, compared to the consensus estimate of $18.55 million. Sell-side analysts expect that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Arteris in a research report on Wednesday, January 21st. Rosenblatt Securities restated a “buy” rating and set a $20.00 price objective on shares of Arteris in a research report on Monday, December 15th. TD Cowen restated a “buy” rating on shares of Arteris in a research note on Wednesday, November 5th. Finally, Jefferies Financial Group upgraded Arteris to a “hold” rating in a research note on Tuesday, October 28th. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $17.50.

Institutional Trading of Arteris

Hedge funds and other institutional investors have recently modified their holdings of the stock. Westerly Capital Management LLC raised its holdings in Arteris by 109.6% in the 3rd quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock valued at $14,392,000 after buying an additional 745,000 shares during the last quarter. Nuveen LLC increased its position in Arteris by 872.3% in the 4th quarter. Nuveen LLC now owns 737,281 shares of the company’s stock valued at $11,428,000 after acquiring an additional 661,454 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Arteris by 144.7% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company’s stock valued at $15,696,000 after acquiring an additional 598,840 shares during the last quarter. Granahan Investment Management LLC lifted its holdings in shares of Arteris by 725.7% during the third quarter. Granahan Investment Management LLC now owns 621,625 shares of the company’s stock worth $6,278,000 after purchasing an additional 546,341 shares during the period. Finally, Informed Momentum Co LLC bought a new stake in shares of Arteris in the fourth quarter worth $5,755,000. Institutional investors own 64.36% of the company’s stock.

Key Stories Impacting Arteris

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Q4 results beat revenue and EPS expectations — Arteris reported ($0.05) EPS vs. consensus ($0.08) and revenue of $20.14M vs. ~$18.6M expected, showing improving margins and top‑line strength. Q4 press release
• Positive Sentiment: Management raised/updated revenue guidance — Q1 2026 revenue guidance of ~$20.5M–$21.5M (vs. consensus ~$18.9M) and FY2026 revenue guidance of ~$89M–$93M (vs. consensus ~$83.4M) point to stronger-than-expected near‑term growth. Guidance release
• Positive Sentiment: Commercial momentum: NXP expanded use of Arteris IP across AI‑enabled SoCs (NPUs, MCUs) and Arteris announced a 4‑billion‑device deployment milestone — both validate product demand in edge AI markets and support medium‑term revenue upside. NXP expansion 4 billion milestone
• Neutral Sentiment: Trading action: volume is elevated versus average, and the stock is trading lower — higher volume means the move has conviction but could reflect profit‑taking or repositioning around the print. (Background market data)
• Neutral Sentiment: Short‑interest reporting is inconsistent across feeds (some entries show 0/NaN). Until exchanges reconcile figures, short‑squeeze risk is unclear and should be treated cautiously.
• Negative Sentiment: Insider and major‑holder selling — CEO K. Charles Janac and Bayview Legacy, LLC disclosed multi‑day sales (including ~47k shares by the CEO on Feb 9 and additional sales on Feb 10). Repeated insider sales can add supply pressure and weigh on sentiment. SEC filing: insider sales

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.